Cohava Gelber - Search Results

Year	Number of Results
2003	1
2007	1
2017	1
2021	1
2022	4
2023	1
2024	1

1

The costs of using unauthenticated, over-passaged cell lines: how much more data do we need?

Hughes P, Marshall D, Reid Y, Parkes H, Gelber C. Hughes P, et al. Among authors: gelber c. Biotechniques. 2007 Nov;43(5):575, 577-8, 581-2 passim. doi: 10.2144/000112598. Biotechniques. 2007. PMID: 18072586 Free article. Review.

2

CT109-SN-38, a Novel Antibody-drug Conjugate with Dual Specificity for CEACAM5 and 6, Elicits Potent Killing of Pancreatic Cancer Cells.

Arias Cardenas KC, Enos CW, Spear MR, Austin DE, Almofeez R, Kortchak S, Pincus L, Guo HB, Dolezal S, Pierce JM, Furth E, Gineste C, Kwon Y, Gelber C. Arias Cardenas KC, et al. Among authors: gelber c. Curr Cancer Drug Targets. 2024 Jan 4. doi: 10.2174/0115680096260614231115192343. Online ahead of print. Curr Cancer Drug Targets. 2024. PMID: 38178674

3

Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription.

DeMarino C, Cowen M, Khatkar P, Cotto B, Branscome H, Kim Y, Sharif SA, Agbottah ET, Zhou W, Costiniuk CT, Jenabian MA, Gelber C, Liotta LA, Langford D, Kashanchi F. DeMarino C, et al. Among authors: gelber c. Cells. 2022 Feb 18;11(4):723. doi: 10.3390/cells11040723. Cells. 2022. PMID: 35203372 Free PMC article.

4

α1-Antitrypsin derived SP16 peptide demonstrates efficacy in rodent models of acute and neuropathic pain.

Wang Z, Martellucci S, Van Enoo A, Austin D, Gelber C, Campana WM. Wang Z, et al. Among authors: gelber c. FASEB J. 2022 Jan;36(1):e22093. doi: 10.1096/fj.202101031RR. FASEB J. 2022. PMID: 34888951 Free PMC article.

5

Restoration of CD4⁺ T Cells during NAFLD without Modulation of the Hepatic Immunological Pattern Is Not Sufficient to Prevent HCC.

Isbell M, Mirshahi F, Aqbi HF, Guo C, Saneshaw M, Koelsch N, Idowu MO, Austin D, Gelber C, Wang XY, Sanyal AJ, Manjili MH. Isbell M, et al. Among authors: gelber c. Cancers (Basel). 2022 Nov 9;14(22):5502. doi: 10.3390/cancers14225502. Cancers (Basel). 2022. PMID: 36428596 Free PMC article.

6

A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers.

Wohlford GF, Buckley LF, Kadariya D, Park T, Chiabrando JG, Carbone S, Mihalick V, Halquist MS, Pearcy A, Austin D, Gelber C, Abbate A, Van Tassell B. Wohlford GF, et al. Among authors: gelber c. PLoS One. 2021 May 6;16(5):e0247357. doi: 10.1371/journal.pone.0247357. eCollection 2021. PLoS One. 2021. PMID: 33956804 Free PMC article. Clinical Trial.

7

Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 - a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein-like Receptor 1- on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction.

Van Tassell BW, Wohlford GF, Del Buono MG, Damonte JI, Markley R, Turlington J, Kadariya D, Talasaz A, Ho J, Marawan A, Thomas GK, Austin D, Gineste C, Gelber C, Abbate A. Van Tassell BW, et al. Among authors: gelber c. J Cardiovasc Pharmacol. 2022 Nov 1;80(5):672-678. doi: 10.1097/FJC.0000000000001331. J Cardiovasc Pharmacol. 2022. PMID: 35881895

8

SERPIN-Derived Small Peptide (SP16) as a Potential Therapeutic Agent against HIV-Induced Inflammatory Molecules and Viral Replication in Cells of the Central Nervous System.

Soler Y, Rodriguez M, Austin D, Gineste C, Gelber C, El-Hage N. Soler Y, et al. Among authors: gelber c. Cells. 2023 Feb 15;12(4):632. doi: 10.3390/cells12040632. Cells. 2023. PMID: 36831299 Free PMC article.

9

Low-Density Lipoprotein Receptor-Related Protein-1 Is a Therapeutic Target in Acute Myocardial Infarction.

Toldo S, Austin D, Mauro AG, Mezzaroma E, Van Tassell BW, Marchetti C, Carbone S, Mogelsvang S, Gelber C, Abbate A. Toldo S, et al. Among authors: gelber c. JACC Basic Transl Sci. 2017 Oct 30;2(5):561-574. doi: 10.1016/j.jacbts.2017.05.007. eCollection 2017 Oct. JACC Basic Transl Sci. 2017. PMID: 30062170 Free PMC article.

10

A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells.

Krueger P, Nitz C, Foster R, MacDonald C, Gelber O, Lalehzadeh G, Goodson R, Winter J, Gelber C. Krueger P, et al. Among authors: gelber c. Cancer Immunol Immunother. 2003 Jun;52(6):367-77. doi: 10.1007/s00262-003-0376-9. Epub 2003 Apr 1. Cancer Immunol Immunother. 2003. PMID: 12669243

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year